I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 97 filers reported holding I MAB in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,610 | -63.8% | 241,371 | -18.0% | 0.00% | – |
| Q2 2023 | $880,654 | -29.1% | 294,533 | -18.0% | 0.00% | – |
| Q1 2023 | $1,242,555 | -44.2% | 359,120 | -32.6% | 0.00% | – |
| Q4 2022 | $2,225,766 | -51.2% | 532,480 | -53.2% | 0.00% | -100.0% |
| Q3 2022 | $4,565,000 | -62.6% | 1,138,338 | +5.5% | 0.00% | -66.7% |
| Q2 2022 | $12,195,000 | +3.3% | 1,079,195 | +48.5% | 0.00% | +50.0% |
| Q1 2022 | $11,801,000 | -32.0% | 726,692 | +98.3% | 0.00% | -33.3% |
| Q4 2021 | $17,365,000 | +13.8% | 366,419 | +74.0% | 0.00% | 0.0% |
| Q3 2021 | $15,264,000 | +28.9% | 210,561 | +49.3% | 0.00% | 0.0% |
| Q2 2021 | $11,843,000 | +64.4% | 141,072 | -5.1% | 0.00% | +50.0% |
| Q1 2021 | $7,203,000 | +854.0% | 148,602 | +828.4% | 0.00% | – |
| Q4 2020 | $755,000 | -71.8% | 16,007 | -71.9% | 0.00% | -100.0% |
| Q3 2020 | $2,676,000 | – | 56,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $293,220 | 0.32% |
| HHLR ADVISORS, LTD. | 6,909,220 | $9,120,170 | 0.20% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $409,859 | 0.14% |
| Maso Capital Partners Ltd | 100,000 | $132 | 0.07% |
| Diametric Capital, LP | 122,953 | $162,297 | 0.07% |
| Artal Group S.A. | 850,000 | $1,122 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 195,546 | $258 | 0.02% |
| Headlands Technologies LLC | 7,394 | $9,760 | 0.01% |
| Temasek Holdings (Private) Ltd | 566,650 | $747,978 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 39,471 | $52,102 | 0.00% |